Chemistry42’s Post

View organization page for Chemistry42, graphic

2,366 followers

Our latest research, driven by PandaOmics, identified MYT1 as a promising therapeutic target for breast and gynecological cancers, with our lead compound 21, demonstrating remarkable selectivity and promising in vivo antitumor efficacy. Through structure-based drug design, we optimized potency and physical properties, offering a potential breakthrough in innovative treatment options for these deadly diseases. To read the paper: https://lnkd.in/gb-J463c #CancerResearch #DrugDiscovery #PrecisionMedicine

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics